KRAS G12C LUNG CANCER

Clinical trials for KRAS G12C LUNG CANCER explained in plain language.

Never miss a new study

Get alerted when new KRAS G12C LUNG CANCER trials appear

Sign up with your email to follow new studies for KRAS G12C LUNG CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1 Not yet finished but already full! 1

New hope for tough lung cancer: Head-to-Head drug showdown

Disease control Ongoing

This study is testing a new drug called divarasib against two existing drugs (sotorasib or adagrasib) for people with a specific type of advanced lung cancer (KRAS G12C-positive NSCLC) that has worsened after prior treatment. The main goal is to see if divarasib can better contro…

Matched conditions: KRAS G12C LUNG CANCER

Phase: PHASE3 • Sponsor: Hoffmann-La Roche • Aim: Disease control

Last updated Mar 31, 2026 12:12 UTC

KRAS G12C LUNG CANCER

Get alerted when new KRAS G12C LUNG CANCER trials appear

New hope for tough lung cancer: Head-to-Head drug showdown